Aspicare
NDC Package 70735-072-32

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Aspicare is clean the affected area • apply a small amount of this product on the area 1 to 3 times daily • may be covered with a sterile bandage • if bandaged, let dry first. Marketed by American Private Label Products, this product is identified by NDC 70735-072 and is authorized under FDA application part333A.

Identification & Billing

NDC Package Code
70735-072-32
Package Description
946 mL in 1 BOTTLE
Product Code
11-Digit Billing Format
70735007232
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Aspicare
Dosage Form
-
Usage Information
Clean the affected area • apply a small amount of this product on the area 1 to 3 times daily • may be covered with a sterile bandage • if bandaged, let dry first

Regulatory & Marketing

Labeler Name
American Private Label Products
FDA Application #
part333A
Marketing Category
OTC MONOGRAPH NOT FINAL - A product marketed pursuant to an Over-the-Counter (OTC) Drug Monograph that is not final.
Start Marketing Date
03-08-2021
Listing Expiration
12-31-2022
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (70735-072). Click a package code to view its specific billing and regulatory data.

236 mL in 1 BOTTLE
473 mL in 1 BOTTLE
3785 mL in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 70735-072-32 identifies a specific commercial package of 946 ml in 1 bottle of Aspicare, labeled by American Private Label Products. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by American Private Label Products on March 08, 2021. The current certification is valid through December 31, 2022.

How is this American Private Label Products product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 70735007232. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
70735-072-32
11-Digit CMS (5-4-2)
70735-0072-32

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.